More on Health Care
WASHINGTON, D.C. – This week, Congressman Roger Marshall, M.D., introduced H.R. 5882, the GENE Therapy Payment Act with Reps. Kurt Schrader (D-OR), Jason Crow (D-CO), Markwayne Mullin (R-OK), Ami Bera, M.D. (D-CA), Mike Kelly (R-PA), and David Schweikert (R-AZ). This legislation will help those with life-threatening illnesses who can benefit from gene therapy treatments.
U.S. Rep. Roger Marshall visited Western Plains Medical Complex on Jan. 22 and answered questions presented by attendees.
Marshall currently serves Kansas’ 1st Congressional District.
Marshall opened first, by talking about what he perceived to be the biggest news: agriculture in Kansas.
He talked about how steps for improvement in agriculture have been taken, highlighting the U.S.-China trade deal being signed and saying the U.S.-Mexico-Canada Agreement, or USMCA, should follow shortly.
When U.S. Rep. Roger Marshall spoke to constituents Thursday morning in Garden City, he told them he brought “good tidings and joy for once.”
Marshall shared his thoughts and concerns with hospital leaders, city officials and community members at 7:30 a.m. at St. Catherine’s Hospital.
He touched on several subjects, those of which included the recent passing of the USMCA trade agreement, Phase 1 of the U.S.-China trade deal and health care.
WASHINGTON, D.C. - Today, Congressman Roger Marshall, M.D., voted NO on H.R. 3, a government price-fixing bill that would decimate private research and development for future lifesaving treatments.